Research suggests that antioxidants found in medicinal mushrooms may help alleviate menstrual pain. Taking daily supplements containing L-ergothioneine—also present in fermented foods—may not only curb existing discomfort but also reduce overall pain by interacting with uterine cells.

“Instead of waiting to address severe pain, EGT [L-ergothioneine] may offer foundational nutritional support, reducing reliance on potent medications and providing a safer pathway for women’s health,” explains Guohua Xiao from Gene III Biotechnology, Nanjing, China.

Menstrual pain, known as dysmenorrhea, ranks among the most prevalent gynecological issues. Prevalence reports range widely from 16% to 91%. This discomfort is often linked to the uterus releasing high levels of inflammatory chemicals called prostaglandins, which cause forceful contractions to shed the lining, sometimes compressing nearby blood vessels and cutting off oxygen supply to muscle tissue.

Dysmenorrhea is also associated with oxidative stress, an imbalance between free radicals and antioxidants in the body that leads to cellular damage.

Current guidelines suggest pain relievers like ibuprofen, which inhibit inflammation and prostaglandin production. Hsiao and his research team hypothesized that L-ergothioneine could provide protective benefits by mitigating oxidative stress in the uterus.

In their investigation, Hsiao and colleagues enlisted 40 women aged 18 to 30 diagnosed with primary dysmenorrhea. None had used painkillers or herbal treatments within the previous month.

Half received 120 milligrams of L-ergothioneine daily for three menstrual cycles, while the rest were given a placebo.

Those taking the supplement reported an initial average pain level of 4.8 out of 10, which decreased significantly over three cycles to scores of 4.1, 3.6, and 2.3. L-ergothioneine’s cell accumulation may enhance its efficacy over time, remarked Hsiao. In contrast, the placebo group did not experience notable pain relief.

The team observed no significant differences in inflammation levels between the experimental and control groups. This aligns with Xiao’s assertion that L-ergothioneine operates via a unique pathway, diverging from traditional pain relief methods. “Menstrual discomfort largely originates from local oxidative stress in uterine tissue. The absence of systemic anti-inflammatory responses suggests a localized antioxidant activity. EGT may directly neutralize free radicals at the source before triggering a systemic inflammatory cascade,” he explained.

Andrea Meyer, a researcher at the University of Melbourne, finds these findings plausible but underscores the necessity for larger studies. “It’s an avenue worth exploring,” she remarked. Hsiao’s team aims to conduct a large-scale multi-center trial soon.

This approach will enhance our understanding of L-ergothioneine’s safety profile, although initial results showed no side effects in either group. Long-term usage of conventional pain relief medications like ibuprofen is linked to increased risks of heart issues and kidney failure and stomach ulcers. Hsiao noted that the cellular transport mechanism of L-ergothioneine ensures it is excreted by the kidneys after reaching saturation.